Through
10/10
Penn Medicine researchers have developed a selective medicine to get rid of old microglia, while also replenishing them with transplanted surrogate cells in their place, suggesting future potential for treating and even preventing neurodegenerative disorders.
The injectable diagnostic, Cytalux, binds to cancerous tissue and glows, making it easier for surgeons to remove tumors completely while sparing healthy tissue.
Penn Medicine’s Renal-Electrolyte & Hypertension division has created a first-of-its-kind fellowship for trainees—a chief DEI fellowship, with Valerie Nwanji as the inaugural chief DEI fellow.
The center for autoimmune research brings together star faculty, powering the next generation of autoimmune disease advances.
Penn Medicine Center for Health Equity Advancement and Penn’s Program for LGBTQ Health works to address the specific health care needs of gender diverse patients.
A new Penn Medicine study finds that late-life depression is not linked to inflammation when other inflammatory conditions are excluded, but that depression occurs independently of inflammation.
On March 18, 160 graduating Perelman School of Medicine students celebrated Match Day at the Jordan Medical Education Center, along with their peers, friends, and family members.
Penn Medicine research have tips for helping insomnia, which has seen an increase throughout the pandemic. It’s not just the disease—worrying about COVID has contributed to lack of sleep.
The results underline the importance of a second dose and include implications for booster shots.
The Pavilion at the Hospital of the University of Pennsylvania has embraced the challenge of design for minimizing sleep disruption in hospitals.